KPV Tripeptide 5mg
Size: 5mg | 99% Purity
M.Wt: 329.43
Formula: Lys-Pro-Val
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Not established
CAS No.: 159492-07-6
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 329.43 g/mol |
| Molecular formula | Lys-Pro-Val |
| CAS number | 159492-07-6 |
| Synonyms | KPV, Lys-Pro-Val, alpha-MSH C-terminal tripeptide |
| Solubility | H2O |
| Storage | -20°C / 3 years |
Peptide sequence
Lys-Pro-ValOnly 9 left in stock
Research reference: View mechanism, literature and identifier graph →
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
KPV Tripeptide 5mg — research reference material
KPV Tripeptide 5mg is supplied by NMChem as a research reference material in a 5mg presentation. Compound class: α-MSH C-terminal tripeptide, characterised in the literature as a anti-inflammatory peptide. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
Research context
Alpha-MSH fragment; studied in anti-inflammatory, gut research. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our KPV research reference. Related compounds in the same research area: PT-141, Melanotan-II, GHK-Cu. You can also compare it side by side on our comparison tool.
Presentation
This listing is the 5mg presentation at >99% stated purity, catalogue reference KPV5.
Identifiers
- CAS number: 159492-07-6
- Molecular formula: Lys-Pro-Val
- Molecular weight: 329.43 g/mol
- Synonyms: KPV, Lys-Pro-Val, alpha-MSH C-terminal tripeptide
- Class: α-MSH C-terminal tripeptide
Format & quality
Supplied as 5mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
Storage
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch.
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. NMChem supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
Frequently asked questions
What is KPV Tripeptide 5mg?
α-MSH C-terminal tripeptide. Alpha-MSH fragment; studied in anti-inflammatory, gut research. NMChem supplies it as a research reference material only.
What is the CAS number for KPV Tripeptide 5mg?
159492-07-6. Molecular formula Lys-Pro-Val. Molecular weight 329.43 g/mol.
How should KPV Tripeptide 5mg be stored?
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.
Zhang L et al. · Advanced healthcare materials · 2024
PubMed PMID 39252648 -
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.
Zhao Y et al. · Acta biomaterialia · 2022
PubMed PMID 35245681 -
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach.
Engelen M et al. · Neurology · 2022
PubMed PMID 36175155
You may also need
Related compounds
